Study of the urinary vascular endothelial growth factor (VEGF) levels in patients with glioblastoma, receiving standard therapy. Hypothesis: that urinary VEGF levels can serve as a predictor of treatment response and survival.
Measurement of urinary VEGF levels pre treatment,immediately after treatment, and 1 month after treatment
Study Type
OBSERVATIONAL
Enrollment
130
tel Aviv Sourasky Medical Center
Tel Aviv, Israel
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.